Filing Details

Accession Number:
0001209191-20-054837
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-14 19:26:20
Reporting Period:
2020-10-12
Accepted Time:
2020-10-14 19:26:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187716 D Ph Lake Mary Polan 9975 Summers Ridge Road
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-10-12 11,743 $275.83 11,141 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The weighted average sale price for these transactions was $275.8252 per share, with a range of $268.54 to $286.72. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.